Common blood pressure drug could make cancer therapy far more powerful

A medication that has long been used to treat high blood pressure could also help make an important class of cancer drugs much more effective, according to new research from Dartmouth Cancer Center (DCC). The study found that the FDA approved drug telmisartan significantly boosted the cancer killing activity of the targeted therapy olaparib, raising the possibility that more patients could benefit from the treatment. The findings were published in The Journal for ImmunoTherapy ...